Molecular Pathology Laboratory, Peter MacCallum Cancer Centre

banner
The TIA funded facility at Peter Mac is fully integrated into the largest cancer specific NATA-accredited molecular pathology laboratory supported by 8 pathologists and 35 molecular pathology scientists. The facility is able to offer state-of-the-art protein, RNA and DNA molecular pathology services providing high throughput routine diagnostic molecular services on multiple test platforms including massive parallel sequencing, to supporting patient care, basic and clinical research with particular emphasis on ancillary biomarker studies in small and large-scale clinical trials. In partnership with collaborators the Peter Mac TIA facility can design clinical grade tumour specific assays for tumour profiling, and prepare of large number of samples for molecular assays through high-throughput automation.
The Molecular Pathology laboratory at the Peter MacCallum Cancer Centre and the Centre for Translational Pathology (CTP) at the University of Melbourne will form partnership in 2016 when they co-locate to the new Victorian Comprehensive Cancer Centre. Both facilities have received investments through the Translating Health Discovery project to establish state-of-the art molecular pathology services using the latest next generation sequencing technologies. 

Accreditation

ISO 15189:2007 and NATA accreditation of genetic testing, molecular genetics, predictive genetic testing, pharmacogenetic testing, genetic testing for mosaic gene variants, assay for a defined mutation or polymorphism, next generation sequencing

Contact information

Contact: Stephen Fox
Email: stephen.fox@petermac.org
Phone: +61 (0)3 9656 1515
Website: http://www.petermac.org/research/conducting-research/molecular-pathology

KEY TECHNOLOGY

SERVICES

Next generation sequencing equipment (HiSeq 2500, MiSeq, Roche GS Junior)

 

Fluidigm Biomark and AccessArray controllers  
PE Janus Chemagen system